Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021-Reference-Cited by-同舟云学术

Suspected Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Reinfections: Incidence, Predictors, and Healthcare Use Among Patients at 238 US Healthcare Facilities, 1 June 2020 to 28 February 2021

Published:2021-08-05 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Lawandi Alexander¹,Warner Sarah¹,Sun Junfeng¹,Demirkale Cumhur Y¹,Danner Robert L¹,Klompas Michael²³,Gundlapalli Adi⁴,Datta Deblina⁴,Harris Aaron M⁴,Morris Sapna Bamrah⁴,Natarajan Pavithra⁴,Kadri Sameer S¹^ORCID

Affiliation:

1. Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland, USA

2. Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA

3. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA

4. CDC COVID-19 Response Team, Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Abstract

Abstract In a retrospective cohort study, among 131 773 patients with previous coronavirus disease 2019 (COVID-19), reinfection with severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) was suspected in 253 patients (0.2%) at 238 US healthcare facilities between 1 June 2020 and 28 February 2021. Women displayed a higher cumulative reinfection risk. Healthcare burden and illness severity were similar between index and reinfection encounters.

Funder

Intramural Research Program of the NIH Clinical Center

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab671/40393461/ciab671.pdf

Reference12 articles.

1. Immunity to SARS-CoV-2: lessons learned;Fergie;Front Immunol,2021

2. Assessment of the risk of SARS-CoV-2 reinfection in an intense re-exposure setting;Abu-Raddad;Clin Infect Dis,2020

3. Risk of reinfection after seroconversion to SARS-CoV-2: a population-based propensity-score matched cohort study;Leidi;Clin Infect Dis,2021